Death induced by CD95 or CD95 ligand elimination

Area of Science:

• Cell Biology
• Cancer Research
• Immunology

Background:

• CD95 (Fas/APO-1) signaling typically induces apoptosis upon binding its ligand, CD95L.
• Cancer cells often evade apoptosis, contributing to tumor development and progression.

Purpose of the Study:

• To investigate the consequences of CD95 or CD95L elimination on cell death.
• To characterize a novel form of cell death and its potential as a cancer therapeutic strategy.

Main Methods:

• Investigated cell death mechanisms in mouse models with tissue-specific deletion of CD95.
• Analyzed cell characteristics including size, mitochondrial ROS production, and DNA damage.
• Assessed the efficacy of single drugs and gene knockdown in blocking this cell death.

Main Results:

• Elimination of CD95/CD95L induced a novel cell death, termed DICE, independent of caspase-8, RIPK1/MLKL, and p53.
• DICE was not inhibited by Bcl-xL and preferentially affected cancer cells.
• Tumor formation was prevented in CD95-deleted mouse models, suggesting CD95 is essential for cancer.
• DICE involves increased cell size, mitochondrial ROS, DNA damage, and resembles necrotic mitotic catastrophe.

Conclusions:

• CD95 is essential for cancer formation, and its elimination triggers a unique cell death pathway (DICE).
• DICE is a promising avenue for cancer therapy due to its resistance to inhibition and preferential targeting of cancer cells.